EU regulator meets to evaluate J&J's one-shot COVID-19 shot
|
March 11, 2021 2:03 AM
AMSTERDAM (AP) — The European Medicines Agency was meeting Thursday to discuss whether Johnson & Johnson’s one-dose coronavirus vaccine should be authorized, a move that would give the European Union a fourth licensed vaccine to try to curb the pandemic amid a stalled inoculation drive.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
